SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-165344
Filing Date
2022-06-01
Accepted
2022-06-01 17:25:02
Documents
17
Period of Report
2022-05-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d339987d8k.htm   iXBRL 8-K 60638
2 EX-10.1 d339987dex101.htm EX-10.1 66565
3 EX-10.2 d339987dex102.htm EX-10.2 76983
4 EX-10.3 d339987dex103.htm EX-10.3 16864
5 EX-99.1 d339987dex991.htm EX-99.1 7874
9 GRAPHIC g339987g0601214420831.jpg GRAPHIC 5361
  Complete submission text file 0001193125-22-165344.txt   414287

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA rgen-20220526.xsd EX-101.SCH 2871
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgen-20220526_lab.xml EX-101.LAB 18757
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgen-20220526_pre.xml EX-101.PRE 11720
11 EXTRACTED XBRL INSTANCE DOCUMENT d339987d8k_htm.xml XML 3507
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Filer) CIK: 0000730272 (see all company filings)

IRS No.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-14656 | Film No.: 22988393
SIC: 2836 Biological Products, (No Diagnostic Substances)